Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
10/2005
10/26/2005EP1587481A2 Sensitive proteasome sensor constructs and methods for their design and use
10/26/2005EP1587479A2 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
10/26/2005EP1587478A2 Pharmaceutical composition
10/26/2005EP1587476A2 Novel compositions and methods in cancer
10/26/2005EP1587474A2 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1587394A2 Oral-care device and system
10/26/2005EP1397133B1 Rapid onset formulation
10/26/2005EP1242048B1 Inhalation particles
10/26/2005EP1163234B1 Pharmaceutical formulations with improved aqueous solubility
10/26/2005EP0984785B1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
10/26/2005CN1688701A Mechanisms of myoblast transfer in treating heart failure
10/26/2005CN1688336A Mycoplasma gallisepticum formulation, its mycoplasma strain k5054 and its application
10/26/2005CN1688331A Nitric oxide and its biomedical significance
10/26/2005CN1688328A A composition for treating AIDS and associated diseases
10/26/2005CN1688297A Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224614C Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/26/2005CN1224612C Acetylenic sulfonamide thiol TACE inhibitors
10/25/2005US6958332 Treating an interleukin-12 overproduction-related disorder; treating rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
10/25/2005US6958156 Bioavailability, solubility; dietetic adjuvant, foods, cosmetics
10/20/2005WO2005097065A1 Composition comprising colony stimulating factor for treatment of a localised bacterial infection and bacterial related disease
10/20/2005WO2005055950A3 Glycopegylated factor ix
10/20/2005WO2005055922A3 Use of benzothiopenes to treat and prevent prostate cancer
10/20/2005WO2005044191A3 Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
10/20/2005WO2005041901A3 Therapeutics using somatostatin agonists
10/20/2005WO2005039497A3 Methods and compositions comprising thalidomide for treatment of fibromyalgia
10/20/2005WO2005037229A3 Methods and compositions for modulating gamete adhesion
10/20/2005WO2005034857A3 Methods and compositions comprising diamines as new anti-tubercular therapeutics
10/20/2005WO2005030139A3 Seneca valley virus based compositions and methods for treating disease
10/20/2005WO2005020923A3 Composition and method for the treatment of cancer and other physiologic conditions based on modulation of the ppar-gamma pathway and her-kinase axis
10/20/2005WO2005016260A3 Prodrugs for the oral and parenteral delivery of amine-containing drugs, amino acids, and peptides
10/20/2005WO2005016244A3 Methods and compositions for the treatment of gastrointestinal disorders
10/20/2005WO2005012320A3 Novel lincomycin derivatives possessing antimicrobial activity
10/20/2005WO2005011574A3 Microporous membrane nebulizers
10/20/2005WO2005009391A3 Antibiotic compound
10/20/2005WO2005009370A3 Beta-carboline compounds and analogues thereof and their use as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
10/20/2005WO2005004798A3 Methods for treating lentivirus infections
10/20/2005WO2004103289A3 Driverse thyroid hormone receptor antagonists and uses thereof
10/20/2005WO2004103266A8 Protein kinase c peptides for use in withdrawal
10/20/2005WO2004096157A3 Treatment of igai deposition diseases
10/20/2005WO2004096147A3 Oxo-pyrimidine compounds
10/20/2005WO2004076410A8 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
10/20/2005WO2004071460A3 Cyclic derivatives as modulators of chemokine receptor activity
10/20/2005WO2004071398A9 Pharmaceutical patch
10/20/2005WO2004064785A3 Cancer therapy sensitizer
10/20/2005WO2004028481A3 Nucleoside derivatives for treating hepatitis c virus infection
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234105 Method of treating of demyelinating diseases or conditions
10/20/2005US20050234050 Ph sensitive prodrugs of 2,6-diisopropylphenol
10/20/2005US20050234035 New salts
10/20/2005US20050233969 Analogues of GLP-1
10/20/2005US20050233961 Methods for treating cancer using vascular endothelial cell growth inhibitor VEGI-192A
10/20/2005US20050232923 Methods and compositions for treating MCP-1 related pathologies
10/20/2005US20050229339 Oral-care device and system
10/20/2005DE29924820U1 Zusammensetzung zum Färben für Keratinfasern mit einem kationischen Direktfarbstoff und einem Silicon Dye composition for keratin fibers, comprising a cationic direct dye and a silicone
10/20/2005DE29924812U1 Zusammensetzung zum Färben für Keratinfasern mit einem kationischen Direktfarbstoff und einem Silicon Dye composition for keratin fibers, comprising a cationic direct dye and a silicone
10/20/2005CA2563276A1 Composition comprising colony stimulating factor for treatment of a localised bacterial infection and bacterial related disease
10/19/2005EP1586309A1 Polymeric delivery formulations of leuprolide with improved efficacy
10/19/2005EP1585827A2 Modulation of protein functionalities
10/19/2005EP1585734A2 Anti-inflammatory medicaments
10/19/2005EP1585547A2 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents
10/19/2005EP1585545A2 Methods of inducing and maintaining immune tolerance
10/19/2005EP1585499A2 Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x
10/19/2005EP1585481A2 Pyrazolopyrimidine compound and process for preparing the same
10/19/2005EP1585480A2 Erbb4 co-crystal
10/19/2005EP1250138B1 Fulvestrant formulation
10/19/2005EP1210344B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/19/2005EP1075260B1 Novel fatty acid analogues for the treatment of secondary restenosis
10/19/2005EP0846173B1 Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma
10/19/2005CN1685064A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/19/2005CN1684668A Sustained release delivery of amphetamine salts
10/19/2005CN1682707A Pharmaceutical composition comprising fenofibrate and process for its preparation
10/19/2005CN1223350C Pharmaceutical combination of ethinylestradiol and drospirenone for use as contraceptive
10/19/2005CN1223343C Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
10/18/2005US6956060 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
10/18/2005US6956054 Treatment of warm-blooded animals having a tumor or non-malignant hypervascularation, by administering a sufficient amount of a cytotoxic agent formulated into a phosphate prodrug form having substrate specificity for microvessel
10/18/2005US6955824 Inhalation composition containing lactose pellets
10/18/2005US6955822 Lactone bearing absorbable polymers
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/18/2005CA2104399C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/13/2005WO2005051291A3 B-cell-targeted toxin for immuno response reduction
10/13/2005WO2005051290A3 Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone
10/13/2005WO2005041867A3 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3’(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline
10/13/2005WO2005037196A3 Substituted 2-arylmethylene-n-aryl-n'-aryl-malonamides and analogs as activators of caspases and inducers of apoptosis
10/13/2005WO2005025515A3 Proteasome pathway inhibitors and related methods
10/13/2005WO2005023183A3 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
10/13/2005WO2005009378A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
10/13/2005WO2004096141A3 Method for promoting uninterrupted sleep by administration of trospium chloride
10/13/2005WO2004096118A3 Composition for improving cognition and memory
10/13/2005WO2004084814A3 High viscosity xanthan polymer preparations
10/13/2005WO2004071447A9 Substituted azole derivatives as therapeutic agents
10/13/2005WO2004064717A3 Cop 1 for treatment of inflammatory bowel diseases
10/13/2005WO2004062578A3 Methods for reducing mortality associated with acute myocardial infarction
10/13/2005US20050228041 Protective and therapeutic uses for tocotrienols
10/13/2005US20050227929 parecoxib sodium and antineoplastic agent chosen from list of 150 compounds, vaccines, and biodrugs such as polyglutamic acid-paclitaxel
10/13/2005US20050227912 Hemoglobin composed 2 polypeptides, each having a normal human hemoglobin alpha chain amino acid sequence, and 2 polypeptides, each having a normal normal bovine hemoglobin beta chain amino acid sequence; at least one polypeptide has a mutation that introduces a polymerization site; nucleic acid
10/13/2005US20050226877 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
10/13/2005DE29924813U1 Zusammensetzung zum Färben für Keratinfasern mit einem kationischen Direktfarbstoff und einem Silicon Dye composition for keratin fibers, comprising a cationic direct dye and a silicone
1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 295